CD8A and neoplasm: Taken together, these results suggest that SFIH combined with anti-PD-1 antibody may promote the infiltration and activity of CD8+ T cells and regulate macrophage differentiation in tumor tissues, thereby enhancing tumor response to anti-PD-1 antibody.